Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest BiO2 Medical Inc. Stories

2014-03-18 16:25:51

SAN ANTONIO, March 18, 2014 /PRNewswire/ -- BiO2 Medical, Inc. is proud to announce the Angel® Catheter Early Feasibility Clinical Study has enrolled its first 3 subjects. Research teams led by Dr. John Holcomb at University of Texas, Houston (Memorial Hermann Hospital) and Dr. Larry Martin at University of Mississippi, Jackson participated in these cases with the first subject enrolled at UT Houston. The Angel® Catheter is an innovative approach to Pulmonary Embolism (PE)...

2013-11-18 08:27:45

SAN ANTONIO, Texas, Nov. 18, 2013 /PRNewswire/ -- BiO2 Medical has achieved Q4 2013 global expansion goals for the Angel® Catheter, a novel Central Venous Catheter (CVC) with a permanently attached retrievable Inferior Vena Cava (IVC) filter to provide Pulmonary Embolism (PE) protection for critically ill patients. The Angel® Catheter is the first IVC filter to receive a prophylactic use indication and was designed for bedside placement in the ICU. In addition to the UK, the...

2013-08-19 04:20:39

SAN ANTONIO, Aug. 19, 2013 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has signed a distribution agreement with Pyramed, a division of United Drug Medical (UDM). This milestone accomplishment grants Pyramed exclusive rights to distribute the Angel® Catheter throughout the UK and Ireland. Pyramed is a dynamic, leading healthcare services...

2013-05-01 08:29:51

SAN ANTONIO, May 1, 2013 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, is among the first to receive U.S. Food and Drug Administration (FDA) approval of their Investigational Device Exemption (IDE) application to begin an Early Feasibility Pilot Study (EFPS) using the Angel(TM) Catheter. The Angel(TM) Catheter is the first to combine the functions of an...

2013-03-11 08:28:10

SAN ANTONIO, March 11, 2013 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, is pleased to announce the first placement of their triple lumen Angel(TM) Catheter in the European Union. The Angel(TM) Catheter is a Nitinol (Nickel Titanium alloy), Inferior Vena Cava (IVC) filter, permanently attached to a central venous catheter (CVC) for the use of...

2012-12-09 16:20:25

SAN ANTONIO, Dec. 9, 2012 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, is pleased to announce CE Mark approval for the triple lumen Angel(TM) Catheter. The Angel(TM) Catheter is a Nitinol, Inferior Vena Cava (IVC) filter, permanently attached to a central venous catheter (CVC) for the use of preventing Pulmonary Embolism (PE) in critically ill patients....

2012-09-07 10:22:40

SAN ANTONIO, Sept. 7, 2012 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently secured $12M in Series C funding. The company worked closely with BiO2 Medical's investment bankers, Pasadera Capital for this Series C round. This funding will allow BiO2 Medical to commercialize the Angel(TM) Catheter. Remeditex Ventures, LLC led the round along with...

2012-05-15 10:25:18

SAN ANTONIO, May 15, 2012 /PRNewswire/ -- BiO2 Medical, Inc. a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, announced today that it has received CE Mark approval for the Angel(TM) Catheter, a Nitinol Inferior Vena Cava (IVC) filter, permanently attached to a central venous catheter (CVC) for the use of preventing Pulmonary Embolism (PE) in critically ill patients. This novel IVC filter/CVC...

2012-03-27 14:21:05

SAN ANTONIO, March 27, 2012 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with manufacturing operations in Golden, Colorado, is proud to announce the first in man clinical study for the Angel(TM) Catheter. The clinical study is being conducted under IRB approval at two medical centers in Medellin, Colombia, Clinica Las Americas, and Hospital Pablo Tobon Uribe. As of today, eight critically ill patients have been enrolled in the study. Dr. Cadavid and...

2012-03-23 10:22:16

SAN ANTONIO, Texas, March 23, 2012 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently completed its $13.7M Series B round of funding, which included the conversion of a $1M State of Texas Emerging Technology Fund (ETF) award. The round was led by San Antonio's Targeted Technology Fund and BiO2 Medical's investment bankers, Pasadera Capital. This...